Title of article :
Negative Correlation of Interleukin-38 Serum Level with Alkaline Phosphatase and Persistent Hepatitis C Infection
Author/Authors :
Rokhtabnak ، Najmeh Department of Immunology - School of Medicine - Shiraz University of Medical Sciences , Ataollahi ، Mohammad Reza Department of Immunology - School of Medicine - Fasa University of Medical Sciences , Asadipour ، Morvarid Department of Immunology - School of Medicine - Shiraz University of Medical Sciences , Ali-Hassanzadeh ، Mohammad Department of Immunology - School of Medicine - Jiroft University of Medical Sciences , Fazeli ، Pooria Department of Immunology - School of Medicine - Shiraz University of Medical Sciences , Khansalar ، Soolmaz Department of Immunology - School of Medicine - Shiraz University of Medical Sciences , Ghani ، Esmaeel Department of Physiology - School of Medicine - Hormozgan University of Medical Sciences , Kalantar ، Kurosh Department of Immunology - School of Medicine - Shiraz University of Medical Sciences
Abstract :
Background: Hepatitis C virus (HCV) is the main cause of acute and chronic liver failure. It seems that interleukin-38 (IL-38), a member of IL-1 cytokine family, has an anti-inflammatory function through binding to the receptor of several cytokines. Objectives: To examine serum level of IL-38 in HCV-infected patients and its correlation with liver enzymes. Methods: We measured serum levels of IL-38 and liver enzymes in 26 untreated and 11 treated HCV-infected patients and 26 healthy individuals using ELISA and biochemistry assay kits, respectively. Results: Serum level of IL-38 was significantly lower in untreated HCV +patients compared to treated patients (P = 0.014) and control group (P 0.0001). In addition, IL-38 levels negatively correlated with alkaline phosphatase (ALP) levels in untreated HCV +patients (r = -0.905, P = 0.042). However, no significant correlations were detected between serum levels of IL-38 and other liver enzymes. Conclusions: Our results suggest a potential anti-inflammatory role for IL-38 in chronic HCV infection which can be implemented to prevent severe hepatic failure in patients with hepatitis C.
Keywords :
Hepatitis C Virus , IL , 38 , Anti , inflammatory , Liver Enzymes , Alkaline Phosphatase (ALP)
Journal title :
Shiraz E Medical Journal
Journal title :
Shiraz E Medical Journal